104 results match your criteria: "Princess Máxima Centre For Paediatric Oncology[Affiliation]"
Pediatr Blood Cancer
September 2025
Princess Máxima Centre For Paediatric Oncology, Utrecht, The Netherlands.
Introduction: As survival of paediatric cancer improves, more emphasis is placed on late adverse effects. However, the dental and periodontal adverse effects of cancer treatments in children remain an underinvestigated complication. This study aims to investigate the prevalence of late clinical dental adverse effects (cDAE) in survivors of paediatric head and neck rhabdomyosarcoma (HNRMS).
View Article and Find Full Text PDFBr J Haematol
August 2025
Department of Paediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark.
Normal karyotype acute myeloid leukaemia (NK-AML) in children is a heterogeneous subgroup with scarce data on characteristics and prognosis. We investigated NK-AML in a large paediatric AML cohort from four trials of the Nordic Society for Paediatric Haematology and Oncology-Dutch Belgian Hongkong (NOPHO-DBH) group. Among 1476 AML patients, we identified 316 NK-AML patients (21%).
View Article and Find Full Text PDFTrials
July 2025
Department of Paediatrics, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
Background: Fatigue is a common symptom in adolescents with a chronic health condition. Persistent fatigue and its impairments may be prevented by early intervention with Booster. Booster is a transdiagnostic blended care intervention that aims to increase fatigue-related self-efficacy (FSE).
View Article and Find Full Text PDFJ Nucl Med
September 2025
Institute for Medical Informatics, Statistics, and Epidemiology, University of Leipzig, Leipzig, Germany.
Cure rates are excellent in classical Hodgkin lymphoma. The challenge is tailoring the treatment to the individual patient to avoid not only overtreatment and treatment-related sequelae but also undertreatment. F-FDG PET is a major tool for guiding response-adapted treatment.
View Article and Find Full Text PDFRadiother Oncol
September 2025
Department of Radiotherapy, Netherlands Cancer Institute, the Netherlands; Department of Radiotherapy, Leiden University Medical Centre, the Netherlands.
Purpose: Soft tissue sarcomas (STS) are a rare and diverse group of tumors. Management of STS typically involves a multidisciplinary approach, including surgery, radiotherapy (RT), and chemotherapy, with surgery remaining the cornerstone of treatment. Radiotherapy, both preoperative and postoperative, has been shown to improve local control.
View Article and Find Full Text PDFBMC Palliat Care
May 2025
Princess Máxima Centre for Paediatric Oncology, Utrecht, The Netherlands.
Background: Children with life-threatening and life-limiting conditions and their families are confronted with many uncertainties, incremental losses, and difficult decisions. Attentiveness to psychosocial care, including psychological, social, and spiritual concerns, is essential during the child's life until end-of-life and during bereavement and determines quality of life and wellbeing of child and family. However, use and integration of psychosocial care is found to be challenging.
View Article and Find Full Text PDFCell Rep
May 2025
Department of Clinical Biochemistry and Institute of Metabolic Science, School of Clinical Medicine, University of Cambridge, Cambridge, UK. Electronic address:
Clonal fitness and plasticity drive cancer heterogeneity. We used expressed lentiviral-based cellular barcodes combined with single-cell RNA sequencing to associate single-cell profiles with in vivo clonal growth. This generated a significant resource of growth measurements from over 20,000 single-cell-derived clones in 110 xenografts from 26 patient-derived breast cancer xenograft models.
View Article and Find Full Text PDFActa Oncol
April 2025
Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Public Health & Surgical Oncology, Erasmus Medical University Centre, Rotterdam, The Netherlands.
Background And Purpose: Soft tissue sarcomas (STS) are a rare and heterogeneous group of tumours. Treatment strategies are based on histological subtype, patient performance status, tumour location, and size. Common treatment modalities include surgery, (neo)adjuvant chemotherapy, and (neo)adjuvant radiotherapy.
View Article and Find Full Text PDFCancers (Basel)
April 2025
EREPL (Espace de Réflexion Ethique des Pays de la Loire, Ethics Reflection Space of the Pays de la Loire Region), 49000 Angers, France.
Background: Childhood, adolescent, and young adult cancer survivors (CAYACS) face significant long-term health risks, yet adherence to long-term follow-up (LTFU) care remains inconsistent. This study explores the concept of akrasia (i.e.
View Article and Find Full Text PDFBr J Cancer
April 2025
Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
Background: Previous studies demonstrated better outcomes for mCRPC (metastatic castration resistant prostate cancer) patients with higher abiraterone exposure (minimal plasma concentration (C) > 8.4 ng/mL), but around 40% of patients experience exposure below this target. Pharmacokinetic (PK)-guided interventions following Therapeutic Drug Monitoring (TDM) could optimise exposure and outcomes.
View Article and Find Full Text PDFEur J Cancer
February 2025
Department of Radiotherapy, Leiden University Medical Centre, the Netherlands. Electronic address:
Purpose: Moderate hypofractionation was adopted to reduce hospital visits during the COVID-19 pandemic aiming to maintain treatment efficacy for soft tissue sarcoma (STS) patients, shifting preoperative schedules from 25 fractions of 2 Gy to 14-15 fractions of 3 Gy. This study evaluates the clinical implications and outcomes of this schedule, focusing on wound complications, radiation toxicity, local tumour control, and distant metastases.
Patients And Methods: Data was collected from patients treated between 01 and 01-2020 and 31-12-2023.
BMC Palliat Care
November 2024
Beatrix Children's Hospital, University Medical Centre Groningen, Department of Pediatrics, University of Groningen, Groningen, the Netherlands.
Background: In paediatric palliative care, children with life-threatening and life-limiting conditions, their families, and their health care professionals often face difficult decisions about treatment, goals of care, and delivery of care. Advance care planning and shared decision-making are strategies that can improve quality of care by discussing goals and preferences on future care. In this paper, we provide recommendations that aim to optimise advance care planning and shared decision-making in paediatric palliative care in the Netherlands.
View Article and Find Full Text PDFBone Marrow Transplant
February 2025
Princess Máxima Centre for Paediatric Oncology, Utrecht, The Netherlands.
J Orthop Surg Res
November 2024
Department of Orthopedic Surgery and Sports Medicine, Amsterdam Movement Sciences, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
Background: Children and young adults needing surgery for a primary malignant bone tumour around the knee face a difficult, life-changing decision. A previous study showed that this population wants to be involved more in the decision-making process and that more involvement leads to less decisional stress and regret. Therefore, a well-designed and standardized decision-making process based on the principles of shared decision-making needs to be designed, implemented, and evaluated.
View Article and Find Full Text PDFClin Pharmacokinet
September 2024
Department of Clinical Pharmacy, University Medical Centre Utrecht, University Utrecht, Utrecht, The Netherlands.
Background And Objective: Systemic corticosteroids have a long history of use in the treatment of autoimmune and inflammatory diseases. Both efficacy and safety show large interindividual variability (IIV), suggesting that corticosteroids may have the potential for individualised dosing strategies to optimise therapy. This systematic review aims to provide an overview of current evidence on the pharmacokinetic (PK) and pharmacodynamic (PD) relationships of systemic corticosteroids in patients with autoimmune and inflammatory diseases.
View Article and Find Full Text PDFPediatr Blood Cancer
November 2024
Faculty of Medicine, University of Southampton, Southampton, UK.
Background: Many studies highlight poor health-related quality of life (HRQoL) in children treated for brain tumours and their parents. However, little is known about the extent to which their informational, healthcare and communication needs regarding HRQoL are met during medical outpatient consultations.
Aim: To explore the experiences of families regarding communication with physicians about HRQoL issues during consultations after treatment for childhood brain tumours.
J Hematol Oncol
August 2024
St. Anna Children's Cancer Research Institute (CCRI), Zimmermannplatz 10, Vienna, A-1090, Austria.
J Hosp Infect
October 2024
Princess Máxima Centre for Paediatric Oncology, Utrecht, The Netherlands.
Br J Cancer
September 2024
Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
Background: Therapeutic drug monitoring (TDM) - performing dose adjustments based on measured drug levels and established pharmacokinetic (PK) targets - could optimise treatment with drugs that show large interpatient variability in exposure. We evaluated the feasibility of TDM for multiple oral targeted therapies. Here we report on drugs for which routine TDM is not feasible.
View Article and Find Full Text PDFBJOG
November 2024
Department of Oncology, KU Leuven, Leuven, Belgium.
Eur J Nucl Med Mol Imaging
October 2024
Institute of Neuroscience and Medicine (INM-3), Research Center Juelich, Juelich, Germany.
Purpose: To provide practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor (SSTR) ligands.
Methods: This joint practice guideline/procedure standard was collaboratively developed by the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the European Association of Neurooncology (EANO), and the PET task force of the Response Assessment in Neurooncology Working Group (PET/RANO).
Results: Positron emission tomography (PET) using somatostatin receptor (SSTR) ligands can detect meningioma tissue with high sensitivity and specificity and may provide clinically relevant information beyond that obtained from structural magnetic resonance imaging (MRI) or computed tomography (CT) imaging alone.
Infect Prev Pract
June 2024
Department of Medical Microbiology, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
Immunother Adv
December 2023
Centre for Translational Immunology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
Immunotherapy has made significant advancements in cancer treatments, improving patients' survival rates and quality of life. Several challenges still need to be addressed, which include the considerable fraction of incomplete curative responses in cancer patients, the development of therapy resistance by tumours, and the occurrence of adverse effects, such as inflammatory and autoimmune complications. Paediatric tumours usually exhibit lower responsiveness to immunotherapies compared to adult tumours.
View Article and Find Full Text PDFActa Neuropathol
November 2023
Department of Neuropathology & The Queen's College, University of Oxford, Oxford, UK.
Microglia are the brain's resident macrophages, which guide various developmental processes crucial for brain maturation, activity, and plasticity. Microglial progenitors enter the telencephalic wall by the 4th postconceptional week and colonise the fetal brain in a manner that spatiotemporally tracks key neurodevelopmental processes in humans. However, much of what we know about how microglia shape neurodevelopment comes from rodent studies.
View Article and Find Full Text PDFPediatr Transplant
November 2023
Pediatric Hepatology Department, La Paz University Hospital, Molecular Hepatology Group, La Paz Institute of Biomedical Research (IdiPAZ), ERN TransplantChild Coordinator, Madrid, Spain.
Background: There is considerable variation in vaccination practices between pediatric transplant centers. This study aims to evaluate active immunization attitudes and practices among ERN-TransplantChild centers and identify potential areas of improvement that could be addressed by shared evidence-based protocols.
Methods: A cross-sectional questionnaire of attitudes and practices toward immunization of pediatric SOT and HSCT candidates and recipients was sent to a representative member of multidisciplinary teams from 27 European centers belonging to the ERN-TransplantChild.